[en] We investigated the time course of the expression of cardiac and renal endothelin systems in tachycardia-induced heart failure in dogs. Eleven beagles underwent rapid pacing at a progressively increased rate over a period of 5 wk, with a weekly clinical examination, echocardiography, measurement of circulating and urinary endothelin-1 (ET-1), and myocardial and renal tissue biopsies. Real-time quantitative PCR was used for determinations of tissue prepro-ET-1 (ppET-1), ET-1-converting enzyme (ECE-1), and ETA and ETB receptor mRNA. Cardiac and renal tissue ET-1 contents were evaluated by immunostaining and measured by radioimmunoassay at autopsy. Rapid pacing caused a progressive increase in end-systolic and end-diastolic ventricular volumes (P<0.05) from week 2 together with a decrease in ejection fraction and in mean velocity of circumferential shortening (P<0.05) from week 1. These changes were tightly correlated to myocardial ppET-1 and renal ETA receptor mRNA and less so to myocardial ECE-1 mRNA, and they occurred before any increase in plasma and urinary ET-1 (P<0.05 from week 4) and clinical signs of heart failure. Renal ppET-1 did not change. Both cardiac and renal ET-1 peptide contents were increased at autopsy. We conclude that tachycardia-induced heart failure in dogs is characterized by an early activation of the cardiac and renal tissue endothelin systems, which occurs before any changes in circulating and urinary ET-1 and is closely related to altered ventricular function.
Disciplines :
Cardiovascular & respiratory systems Anatomy (cytology, histology, embryology...) & physiology
Author, co-author :
Motte, S.
van Beneden, R.
Mottet, J.
Rondelet, B.
Mathieu, M.
Havaux, X.
Lause, P.
Clercx, Cécile ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Pathologie médicale des petits animaux
Ketelslegers, J. M.
Naeije, R.
Mc Entee, Kathleen ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Sémiologie et clinique médicale des petits animaux
Language :
English
Title :
Early activation of cardiac and renal endothelin systems in experimental heart failure
Publication date :
01 December 2003
Journal title :
American Journal of Physiology - Heart and Circulatory Physiology
ISSN :
0363-6135
eISSN :
1522-1539
Publisher :
Amer Physiological Soc, Bethesda, United States - Maryland
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Brunner F and Doherty AM. Role of ETB receptors in local clearance of endothelin-1 in rat heart: studies with the antagonists PD 155080 and BQ-788. FEBS Lett 396: 238-242, 1996.
Choussat R, Hittinger L, Barbe F, Maistre G, Carayon A, Crozatier B, and Su J. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs. Cardiovasc Res 39: 580-588, 1998.
Clozel M, Loffler BM, Breu V, Hilfiger L, Maire JP, and Butscha B. Downregulation of endothelin receptors by autocrine production of endothelin. Am J Physiol Cell Physiol 265: C188-C192, 1993.
Ding SS, Qiu C, Hess P, Xi JF, Clozel JP, and Clozel M. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure. Cardiovasc Res 53: 963-970, 2002.
Ensinck JW, Shepard C, Dudl RJ, and Williams RH. Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma. J Clin Endocrinol Metab 35: 463-467, 1972.
Fraccarollo D, Hu K, Galuppo P, Gaudron P, and Ertl G. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction. Circulation 96: 3963-3973, 1997.
Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, and Winaver J. Bosentan improves renal regional blood flow in rats with experimental congestive heart failure. Eur J Pharmacol 310: 193-196, 1996.
Hocher B, Thone-Reineke C, Bauer C, Raschack M, and Neumayer HH. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 35: 175-189, 1997.
Ishikawa T, Yanagisawa M, Kimura S, Gotto K, and Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol Heart Circ Physiol 255: H970-H973, 1988.
Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, and Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 98: 2065-2073, 1998.
Jeffcoate SL and White N. Use of benzamidine to prevent the destruction of thyrotropin-releasing hormone (TRH) by blood. J Clin Endocrinol Metab 38: 155-157, 1974.
Kaddoura S, Firth JD, Boheler KR, Sudgren PH, and Poole-Wilson PA. Endothelin-1 is involved in epinephrine-induced ventricular hypertrophy in vivo. Circulation 93: 2068-2079, 1996.
Kanno K, Hirata Y, Tsujino M, Imai T, Shichiri M, Ito H, and Marumo F. Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem Biophys Res Commun 194: 1282-1287, 1993.
Keene BW, Kittleson ME, Atkins CE, Rush JE, Eicker SW, Pion P, and Regitz V. Modified transvenous endomyocardial biopsy technique in dogs. Am J Vet Res 51: 1769-1772, 1990.
Kobayashi T, Miyauchi T, Sakai S, Kobayashi M, Yamaguchi I, Goto K, and Sugishita Y. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in the failing rat heart. Am J Physiol Heart Circ Physiol 276: H1197-H1206, 1999.
Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 29: 2-26, 1997.
Luchner A, Jougasaki M, Friedrich E, Borgeson DD, Stevens TL, Redfield MM, Riegger GAJ, and Burnett JC Jr. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure. Am J Physiol Endocrinol Metab 279: E974-E979, 2000.
MacCarthy PA, Grocott-Mason R, Prendergast BD, and Shah AM. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart. Studies with an intracoronary ETA receptor antagonist. Circulation 101: 142-147, 2000.
Margulies KB, Hildebrand FL Jr, Lerman A, Perrella MA, and Burnett JC Jr. Increased endothelin in experimental heart failure. Circulation 82: 2226-2230, 1990.
McMurray JJ, Ray SG, Abdullah I, Dargie HJ, and Morton JJ. Plasma endothelin in chronic heart failure. Circulation 85: 1374-1379, 1992.
Modesti PA, Cecioni I, Costoli A, Poggesi L, Galanti G, and Neri Serneri GG. Renal endothelin in heart failure and its relation to sodium excretion. Am Heart J 140: 617-623, 2000.
Molenaar P, O'Reilly G, Starkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, and Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538, 1993.
Morawietz H, Goettsch W, Szibor M, Barton M, Shaw S, Hakim K, Zerkowski HR, and Holtz J. Angiotensin-converting enzyme inhibitor therapy prevents upregulation of endothelin-converting enzyme-1 in failing human myocardium. Biochem Biophys Res Commun 295: 1057-1061, 2002.
Morawietz H, Goettsch W, Szibor M, Barton M, Shaw S, Hakim K, Zerkowski HR and Holtz J. Increased expression of endothelin-converting enzyme-1 in failing human myocardium. Clin Sci (Lond) 103, Suppl 48: S237-S240, 2002.
Mulder P, Richard V, Bouchart F, Derumeaux G, Miinter K, and Thuillez C. Selective ETA receptor blockade prevents left ventricular remodelling and deterioration of cardiac function in experimental heart failure. Cardiovasc Res 39: 600-608, 1998.
Mullan DM, Bell D, Kelso EJ, and McDermott BJ. Involvement of endothelin receptor ETA and ETB receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes. J Cardiovasc Pharmacol 29: 350-359, 1997.
Neri Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, Sani G, and Modesti PA. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res 86: 377-385, 2000.
Nishimura J, Chen X, Jahan H, Shikasho T, Kobayashi S, and Kanaide H. cAMP induces up-regulation of ETA receptor mRNA and increases responsiveness to endothelin-1 of aortic muscle cells in primary culture. Biochem Biophys Res Commun 188: 719-726, 1992.
Oie E, Vinge LE, Tonnessen T, Grogaard HK, Kjekshus H, Christensen G, Smiseth OA, and Attramadal H. Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Physiol Heart Circ Physiol 273: H1727-H1736, 1997.
Onishi K, Ohno M, Little WC, and Cheng CP. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in left heart failure. J Pharmacol Exp Ther 288: 1214-1222, 1999.
Osborne CA, Bartges JW, Polzin DJ, Lulich JP, Johnston GR, and Cox V. Percutaneous needle biopsy of the kidney. Indications, applications, technique and complications. Vet Clin North Am Small Anim Pract 26: 1461-1504, 1996.
Pieske B, Beyermann B, Breu V, Löffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, and Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99: 1802-1809, 1999.
Ponicke K, Vogelsang M, Heinroth M, Becker K, Zolk O, Bohm M, Zerkowski HR, and Brodde OE. Endothelin receptors in the failing and nonfailing human heart. Circulation 97: 744-751, 1998.
Pousset F, Isnard R, Lechat P, Kalotka H, Carayon A, Maistre G, Escolano S, Thomas D, and Komajda M. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 18: 254-258, 1997.
Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S, McEntee K, Wauthy P, Salmon I, Ketelslegers JM, and Naeije R. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107: 1323-1329, 2003.
Sahn DJ, DeMaria A, Kisslo J, and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
Sakai S, Miyachi T, Sakurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, and Sugishita Y. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation 93: 1214-1222, 1996.
Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, and Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation 95: 1918-1929, 1997.
Stevens TL, Borgeson DD, Luchner A, Wennberg PW, Redfield MM, and Burnett JC Jr. A modified model of tachycardia-induced cardiomyopathy: insights into humoral and renal adaptations. In: Pathophysiology of Tachycardia-Induced Heart Failure, edited by Spinale FG. Armonk NY: Futura, 1996, p. 133-151.
Suzuki T, Kumazaki T, and Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 193: 823-830, 1993.
Tadano K, Suzuki J, Hanada K, Nakao M, Nakao R, Uehara S, Ohta H, Miyauchi T, and Nishikibe M. Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing. J Pharmacol Exp Ther 298: 729-736, 2001.
Thomas P, Liu E, Webb M, Mukhertjee R, Hebbar L, and Spinale F. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol Heart Circ Physiol 271: H2629-H2637, 1996.
Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS, and Moses BL. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 7: 247-252, 1993.
Winer BJ. Statistical Principles in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971, p 514-603.
Winer J, Jung CK, Shackel I, and Williams PL. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49, 1999.
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, de Wit D, and Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyses the proteolytic activation of big endothelin-1. Cell 78: 473-485, 1994.
Yamamoto K, Masuyama T, Sakata Y, Doi R, Ono K, Mano T, Kondo H, Kuzuya T, Miwa T, and Masatsugu H. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and "overdrive" of the endothelin system. Cardiovasc Res 46: 421-432, 2000.
Yamamoto T, Wada A, Ohnishi M, Tsutamoto T, Fujii M, Takayama T, Wang X, Kurokawa K, and Kinoshita M. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure. Clin Sci (Lond) 103, Suppl 48: 258S-262S, 2002.
Yoshimura H, Nishimura J, Sakihara C, Kobayashi S, Takahashi S, and Kanaide H. Expression and function of endothelins, endothelin receptors, and endothelin converting enzyme in the porcine trachea. Am J Respir Cell Mol Biol 17: 471-480, 1997.
Zolk O, Quattek J, Seeland U, El-Armouche A, Eschenhagen T, and Böhm M. Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2) 27 rats. Cardiovasc Res 53: 363-371, 2002.
Zolk O, Quattek J, Sitzler G, Schrader T, Nickering G, Schnabel P, Shimada K, Takahishi M, and Bohm M. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99: 2118-2123, 1999.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
